
The global market for Cross-border Medical Tourism was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Cross-border Medical Tourism was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cross-border Medical Tourism was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Cross-border Medical Tourism was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Cross-border Medical Tourism include Apollo Hospitals Group, Bumrungrad International Hospital, KPJ Healthcare, Christus Muguerza Hospital, World Med Assistance, Global Medical Tourism, Remed Health, Med Elite and ²Ï³Ü¾±°ùó²Ô²õ²¹±ô³Ü»å, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cross-border Medical Tourism, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cross-border Medical Tourism by region & country, by Type, and by Application.
The Cross-border Medical Tourism market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cross-border Medical Tourism.
Âé¶¹Ô´´ Segmentation
By Company
Apollo Hospitals Group
Bumrungrad International Hospital
KPJ Healthcare
Christus Muguerza Hospital
World Med Assistance
Global Medical Tourism
Remed Health
Med Elite
²Ï³Ü¾±°ùó²Ô²õ²¹±ô³Ü»å
Neolife
Segment by Type:
Cosmetic Surgery
Cancer Treatment
Cardiovascular Treatment
Others
Segment by Application
Adult
Children
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cross-border Medical Tourism manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cross-border Medical Tourism in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cross-border Medical Tourism in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Âé¶¹Ô´´ Overview
1.1 Cross-border Medical Tourism Product Introduction
1.2 Global Cross-border Medical Tourism Âé¶¹Ô´´ Size Forecast
1.3 Cross-border Medical Tourism Âé¶¹Ô´´ Trends & Drivers
1.3.1 Cross-border Medical Tourism Industry Trends
1.3.2 Cross-border Medical Tourism Âé¶¹Ô´´ Drivers & Opportunity
1.3.3 Cross-border Medical Tourism Âé¶¹Ô´´ Challenges
1.3.4 Cross-border Medical Tourism Âé¶¹Ô´´ Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cross-border Medical Tourism Players Revenue Ranking (2023)
2.2 Global Cross-border Medical Tourism Revenue by Company (2019-2024)
2.3 Key Companies Cross-border Medical Tourism Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cross-border Medical Tourism Product Offered
2.5 Key Companies Time to Begin Mass Production of Cross-border Medical Tourism
2.6 Cross-border Medical Tourism Âé¶¹Ô´´ Competitive Analysis
2.6.1 Cross-border Medical Tourism Âé¶¹Ô´´ Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cross-border Medical Tourism Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cross-border Medical Tourism as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cosmetic Surgery
3.1.2 Cancer Treatment
3.1.3 Cardiovascular Treatment
3.1.4 Others
3.2 Global Cross-border Medical Tourism Sales Value by Type
3.2.1 Global Cross-border Medical Tourism Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cross-border Medical Tourism Sales Value, by Type (2019-2030)
3.2.3 Global Cross-border Medical Tourism Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adult
4.1.2 Children
4.2 Global Cross-border Medical Tourism Sales Value by Application
4.2.1 Global Cross-border Medical Tourism Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cross-border Medical Tourism Sales Value, by Application (2019-2030)
4.2.3 Global Cross-border Medical Tourism Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cross-border Medical Tourism Sales Value by Region
5.1.1 Global Cross-border Medical Tourism Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cross-border Medical Tourism Sales Value by Region (2019-2024)
5.1.3 Global Cross-border Medical Tourism Sales Value by Region (2025-2030)
5.1.4 Global Cross-border Medical Tourism Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cross-border Medical Tourism Sales Value, 2019-2030
5.2.2 North America Cross-border Medical Tourism Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cross-border Medical Tourism Sales Value, 2019-2030
5.3.2 Europe Cross-border Medical Tourism Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cross-border Medical Tourism Sales Value, 2019-2030
5.4.2 Asia Pacific Cross-border Medical Tourism Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cross-border Medical Tourism Sales Value, 2019-2030
5.5.2 South America Cross-border Medical Tourism Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cross-border Medical Tourism Sales Value, 2019-2030
5.6.2 Middle East & Africa Cross-border Medical Tourism Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cross-border Medical Tourism Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cross-border Medical Tourism Sales Value
6.3 United States
6.3.1 United States Cross-border Medical Tourism Sales Value, 2019-2030
6.3.2 United States Cross-border Medical Tourism Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cross-border Medical Tourism Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cross-border Medical Tourism Sales Value, 2019-2030
6.4.2 Europe Cross-border Medical Tourism Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cross-border Medical Tourism Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cross-border Medical Tourism Sales Value, 2019-2030
6.5.2 China Cross-border Medical Tourism Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cross-border Medical Tourism Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cross-border Medical Tourism Sales Value, 2019-2030
6.6.2 Japan Cross-border Medical Tourism Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cross-border Medical Tourism Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cross-border Medical Tourism Sales Value, 2019-2030
6.7.2 South Korea Cross-border Medical Tourism Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cross-border Medical Tourism Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cross-border Medical Tourism Sales Value, 2019-2030
6.8.2 Southeast Asia Cross-border Medical Tourism Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cross-border Medical Tourism Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cross-border Medical Tourism Sales Value, 2019-2030
6.9.2 India Cross-border Medical Tourism Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cross-border Medical Tourism Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Apollo Hospitals Group
7.1.1 Apollo Hospitals Group Profile
7.1.2 Apollo Hospitals Group Main Business
7.1.3 Apollo Hospitals Group Cross-border Medical Tourism Products, Services and Solutions
7.1.4 Apollo Hospitals Group Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.1.5 Apollo Hospitals Group Recent Developments
7.2 Bumrungrad International Hospital
7.2.1 Bumrungrad International Hospital Profile
7.2.2 Bumrungrad International Hospital Main Business
7.2.3 Bumrungrad International Hospital Cross-border Medical Tourism Products, Services and Solutions
7.2.4 Bumrungrad International Hospital Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.2.5 Bumrungrad International Hospital Recent Developments
7.3 KPJ Healthcare
7.3.1 KPJ Healthcare Profile
7.3.2 KPJ Healthcare Main Business
7.3.3 KPJ Healthcare Cross-border Medical Tourism Products, Services and Solutions
7.3.4 KPJ Healthcare Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.3.5 Christus Muguerza Hospital Recent Developments
7.4 Christus Muguerza Hospital
7.4.1 Christus Muguerza Hospital Profile
7.4.2 Christus Muguerza Hospital Main Business
7.4.3 Christus Muguerza Hospital Cross-border Medical Tourism Products, Services and Solutions
7.4.4 Christus Muguerza Hospital Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.4.5 Christus Muguerza Hospital Recent Developments
7.5 World Med Assistance
7.5.1 World Med Assistance Profile
7.5.2 World Med Assistance Main Business
7.5.3 World Med Assistance Cross-border Medical Tourism Products, Services and Solutions
7.5.4 World Med Assistance Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.5.5 World Med Assistance Recent Developments
7.6 Global Medical Tourism
7.6.1 Global Medical Tourism Profile
7.6.2 Global Medical Tourism Main Business
7.6.3 Global Medical Tourism Cross-border Medical Tourism Products, Services and Solutions
7.6.4 Global Medical Tourism Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.6.5 Global Medical Tourism Recent Developments
7.7 Remed Health
7.7.1 Remed Health Profile
7.7.2 Remed Health Main Business
7.7.3 Remed Health Cross-border Medical Tourism Products, Services and Solutions
7.7.4 Remed Health Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.7.5 Remed Health Recent Developments
7.8 Med Elite
7.8.1 Med Elite Profile
7.8.2 Med Elite Main Business
7.8.3 Med Elite Cross-border Medical Tourism Products, Services and Solutions
7.8.4 Med Elite Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.8.5 Med Elite Recent Developments
7.9 ²Ï³Ü¾±°ùó²Ô²õ²¹±ô³Ü»å
7.9.1 ²Ï³Ü¾±°ùó²Ô²õ²¹±ô³Ü»å Profile
7.9.2 ²Ï³Ü¾±°ùó²Ô²õ²¹±ô³Ü»å Main Business
7.9.3 ²Ï³Ü¾±°ùó²Ô²õ²¹±ô³Ü»å Cross-border Medical Tourism Products, Services and Solutions
7.9.4 ²Ï³Ü¾±°ùó²Ô²õ²¹±ô³Ü»å Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.9.5 ²Ï³Ü¾±°ùó²Ô²õ²¹±ô³Ü»å Recent Developments
7.10 Neolife
7.10.1 Neolife Profile
7.10.2 Neolife Main Business
7.10.3 Neolife Cross-border Medical Tourism Products, Services and Solutions
7.10.4 Neolife Cross-border Medical Tourism Revenue (US$ Million) & (2019-2024)
7.10.5 Neolife Recent Developments
8 Industry Chain Analysis
8.1 Cross-border Medical Tourism Industrial Chain
8.2 Cross-border Medical Tourism Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cross-border Medical Tourism Sales Model
8.5.2 Sales Channel
8.5.3 Cross-border Medical Tourism Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Apollo Hospitals Group
Bumrungrad International Hospital
KPJ Healthcare
Christus Muguerza Hospital
World Med Assistance
Global Medical Tourism
Remed Health
Med Elite
²Ï³Ü¾±°ùó²Ô²õ²¹±ô³Ü»å
Neolife
Ìý
Ìý
*If Applicable.
